HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Zacks #1 Rank
See how a purely mathematical analysis of earnings estimate revisions returns over 27% per year on average. Click Here to Learn More.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


OSIP: Osi Pharmaceuticals Inc - Stock News Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Company News |  Zacks Commentary
OSI PHARMACEUTICALS INC (NASD)
OSIP 32.79 -0.07 (-0.21%) Vol.  346,990 16.00 CST

Nov 20, 2009 BiomedReports: News and FDA Updates for OSI Pharmaceuticals (NASDAQ:OSIP), Perrigo (Nasdaq:PRGO), Sensient (NYSE:SXT)
Nov 19, 2009 OSI Pharmaceuticals to Webcast its R&D Analyst Day on Thursday, December 3rd
Nov 17, 2009 ODAC will Review Tarceva for Maintenance Therapy in Advanced Non-Small Cell Lung Cancer
Nov 17, 2009 BiomedReports: News and FDA Updates for NovaDel (NYSE:NVD), Neogen (Nasdaq:NEOG), OSI Pharmaceuticals (NASDAQ:OSIP)
Nov 16, 2009 OSI Pharmaceuticals Announces Tarceva to Be Reviewed by the FDA's Oncologic Drugs Advisory Committee for Use as a First-Line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer
Nov 11, 2009 OSI Pharmaceuticals to Make Presentation at the Lazard Capital Markets Annual Healthcare Conference
Nov 09, 2009 OSI Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference on Tuesday, November 17, 2009
Nov 09, 2009 OSI Pharmaceuticals (OSIP) In Tight Support/Resistance Range And On Investors Observer Momentum Plays List
Oct 28, 2009 BiomedReports: News and FDA Updates for OSI (NASDAQ:OSIP), Manhattan Scientifics (OTCBB:MHTX), Inhibitex (NASDAQ:INHX), Roche (OTC:RHHBY)
Oct 27, 2009 xtremepicks.com: www.Xtremepicks.Com: Xtremepicks Alerts October 27, 2009 : OSIP, ESLR, ARRS and CPIX
Oct 27, 2009 OSI Pharmaceuticals to Present at the Oppenheimer 20th Annual Healthcare Conference on Tuesday, November 3, 2009
Oct 22, 2009 BiomedReports: News and FDA Updates for Dynavax (NASDAQ:DVAX), OSI Pharmaceuticals (NASDAQ:OSIP)
Oct 21, 2009 OSI Pharmaceuticals, Inc. Announces Third Quarter 2009 Financial Results
Oct 20, 2009 Groundbreaking Agreement Brings OSI-930 to China
Oct 20, 2009 Crown Equity Holdings, Inc.: CRWENews Highlights: SCR, GE
 
ZACKS COMMENTARY FOR OSIP
Nov 11, 2009 Zacks Blog: Zacks Analyst Blog Highlights: Enzon, Merck, OSI Pharmaceuticals, Pfizer and Bank of America Corporation
Nov 10, 2009 Zacks Blog: Enzon Beats, Announces Sell-off
Oct 26, 2009 Zacks Equity Research: Report for OSIP
Oct 23, 2009 Zacks Blog: OSI Pharma Easily Beats Estimate
Oct 08, 2009 Zacks Blog: European Approval for Cimzia
Jul 29, 2009 Zacks Blog: Earnings Preview: ALTH
Jul 23, 2009 Zacks Blog: OSI Pharma Reports Lower Profit in Q2
Jul 14, 2009 Zacks Blog: Company News for July 14, 2009
Jul 13, 2009 Zacks Blog: OSIP Encouraged by Tarceva Study
Jun 22, 2009 Zacks Blog: OSIP's Tarceva Expansion Needed
Feb 12, 2009 Zacks Blog: OSIP Breaks 200-day MA
Feb 03, 2009 Zacks Blog: OSI Pharma Scores with Tarceva

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research